athens-2005-sw1-zervas - World Psychiatric Association
Download
Report
Transcript athens-2005-sw1-zervas - World Psychiatric Association
COGNITION AND ECT
Iannis M. Zervas, M.D.
Athens University Medical School
ECT effects on cognition
Memory
Other
ECT effects on memory
Apparent
Real
Apparent effects-positive
Memory improvement (!)
Inaccurate psychologically but
crucial from a psychiatric viewpoint
Apparent effects-negative
Residual psychopathology
Drug effects
New psychosis
Unmasking of dementia
Subjective complaints
(depression)
(psych, anesthesia, other)
(young, new onset)
(old)
(various motives)
Real effects
Disorientation
Anterograde amnesia
Retrograde amnesia
Retrograde
remote
recent
ECT
Anterograde
Time course
of memory disturbance
Acute
Subacute
Long-term
ECT effects on non-memory cognition
Acute phase ( 0-7 hours)
General intelligence
Perceptual function
Attention
*No change can be attributed to ECT
no change*
no change*
-left side inattention
-reduced speed in
vigilance tasks
ECT effects on non-memory cognition
Subacute phase (7-72 hours)
Intelligence
Language
no change or improved
verbal fluency
may be affected
Perceptual/Visuospatial
Motor function
Higher cognitive/ frontal
no change
no change
no change
ECT effects on non-memory cognition
Middle subacute period (72 hrs -1 wk)
Intelligence
Language
Perceptual
Attention/frontal
improvement MMSE
improvement (rel. to depression)
improvement
no change (better in reaction time)
ECT effects on non-memory cognition
Late subacute phase (1 wk -7 mo)
Intelligence
Language
Perceptual
Motor
Attention/frontal
improved (or no change due to ECT)
no change (due to ECT)
improved (normalized depr. changes)
improved ( trend)
improved mental shifts
no change in vigilance
Memory disturbance
Acute phase
Postictal
Interictal
Acute memory disturbance
Postictal
Acute memory disturbance
Interictal
Subacute memory disturbance
Memory effects
Large inter-individual variability in:
Severity
Persistence (Reversibility)
Subjective tolerance / discomfort
Factors affecting severity
Number of treatments
Frequency
Stimulus intensity
Electrode placement
Waveform
Oxygenation
Medications
Factors affecting persistence
Prolonged post-ictal disorientation
Pre-ECT cognitive impairment
Probably age, neurological illness
(e.g. Parkinson’s disease)
other obvious factors never studied
( i.e. substance abuse, medications,
cardiac output status, etc)
Attempts to ameliorate
Non-pharmacological methods ( schedule,
oxygen, electrode placement, etc)
Various pharmacological methods
ECT memory disturbance
Pharmacological attempts
ACTH
dexamethasone
naloxone
vasopressin
T4
TRH
physostigmine
caffeine
Ca++ channel blockers
piracetam
pramiracetam
inositol
ergoloid mesylates
herbal preparations
Memory systems involved in ECT
with related brain structures
Short-term
memory or
immediate
Verbal
Visual
Neocortex
Long-term Declarative
memory
Learning
Medial temporal Lobe
Retrieval
Diencephalon
Priming
Striatum/cerebellum
Procedural
Neocortex
NonDeclarative
Immediate / short-term memory
(working memory)
Prefrontal cortex involved; Medial
temporal lobe lesions spare this subtype
Dysfunctions after course of ECT
(patients learn OK but forget fast)
Returns to baseline after a few weeks
Old patients more sensitive plus difficulty
to learn new material. In 6 months no
difference with younger.
Declarative memory*
New learning (anterograde amnesia)
Transitory difficulties in retaining new
information and in recognizing or retrieving
information learned some time previously
Increases with increasing number of
treatments
Not associated with global cognitive
dysfunction
Recovers within a few weeks after ECT
*conscious recollection of facts and events, autobiographical or public
Declarative memory
Remote memory (Retrograde amnesia)
Deficits in recall of autobiographical facts
and events learned before ECT
Temporal gradient ( more so for events
within the year prior to ECT)
Worse with bilateral
Worse with sinewave treatments
Reversible by 3 -6 months
Non-declarative memory*
No change
includes
• procedural learning ( neostriatum)
• classical conditioning ( amygdala, cerebellum)
•
perceptual priming (cortical areas)
Implicit memory**
No change
*non-conscious recollection of performance
**non-conscious ability to learn spatial and temporal data
Neurobiological correlates
Transient disruption of mechanisms for
consolidation, retention, maintenance
Disruption of LTP related to persistence of
stimuli, specificity /plasticity, associative
organization
Possibly causes massive long-term induction of
potentiation and saturates synaptic strengths
obstructing formation of new memories
Time course of memory disturbance coincides
with LTP disruption
Related to mesial temporal lobe; less affected
by bifrontal treatments
Neurochemical correlates
ECT inhibits activity of central cholinergic
system= decrease in cholinergic
transmission
Excessive release of excitatory amino
acids and activation of their receptors
Ketamine ( NMDA antagonist) may be
better alternative for anesthesia
In support of
Medial Temporal Lobe (MTL)Dysfunction
in ECT memory disturbance
role of MTL in memory
low seizure threshold in
hippocampus
LTP disruption (ECS) is a
hippocampal process
theta activity in left frontal and
temporal sites associated with
greater retrograde amnesia for
autobiographical information
In support of involvement of
Prefrontal Cortex (PFC)
in ECT memory dysfunction
Most profound physiological effects of ECT
found in PFC -reductions in CB,
-reductions in metabolic rate,
-EEG slow wave activity
Retrograde amnesia greater for public events
( PFC) not autobiographical (hippocampus)
Tests of frontal lobe function can co-vary with
tests of retrograde amnesia
SUMMARY
ECT affects selectively memory
parameters
There is large inter-individual variability
Memory disturbance is not related to
clinical effects on depression
SUMMARY
Memory disturbance is in general
reversible
In some cases some retrograde amnesia
for sporadic events (public mainly) may
persist
Both mesial temporal lobe and prefrontal
cortex (lowest seizure threshold in brain)
have been implicated in memory trouble
CONCLUSION
One should keep in mind that for most
patients memory improves
Cost-benefit analysis for the patient
Simple measures can contain disturbance
Memory parameters should be monitored
systematically - best to acknowledge and
support / educate patient and family